Immunocore rises, Vor doubles in value as busy week concludes for IPOs
Five of 10 biotechs debuting this week post big gains
With its market cap clearing $1.8 billion at the final bell, Immunocore was among four companies that posted gains of at least double digits Friday among the seven biotechs that priced IPOs ahead of the NASDAQ session. Hematologic oncology company Vor doubled in value, posting the biggest percentage gain.
The flood of offerings capped a busy week for IPOs, with 10 biotechs listing on NASDAQ. Most prominently, cell and gene therapy technology aggregator Sana Biotechnology Inc. (NASDAQ:SANA) raised $587.5 million ahead of Thursday’s session in what could become the largest pure-play biotech offering in history, pending the exercise of the underwriters’ overallotment. Sana finished the week up 56% with a market cap of almost $7.2 billion...